The role of upfront autologous stem cell transplantation in high-risk younger patients with primary central nervous system lymphoma-Reference-Cited by-同舟云学术

The role of upfront autologous stem cell transplantation in high-risk younger patients with primary central nervous system lymphoma

Published:2016-03-28 Issue:3 Volume:174 Page:444-453
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Cho Hyunsoo¹,Chang Jong Hee²,Kim Yu Ri³,Kim Soo-Jeong¹,Chung Haerim¹,Park Hyunsung¹,Lee Jung Yeon¹,Jang Ji Eun¹,Kim Yundeok¹,Kim Se Hoon⁴,Yang Woo Ick⁴,Suh Chang-Ok⁵,Cheong June-Won¹,Min Yoo Hong¹,Kim Jin Seok¹

Affiliation:

1. Division of Haematology; Department of Internal Medicine; Severance Hospital; Yonsei University College of Medicine; Seoul South Korea

2. Department of Neurosurgery; Severance Hospital; Yonsei University College of Medicine; Seoul South Korea

3. Department of Internal Medicine; Gangnam Severance Hospital; Yonsei University College of Medicine; Seoul South Korea

4. Department of Pathology; Severance Hospital; Yonsei University College of Medicine; Seoul South Korea

5. Department of Radiation Oncology; Severance Hospital; Yonsei University College of Medicine; Seoul South Korea

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14069/fullpdf

Reference29 articles.

1. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma;Abrey;Journal of Clinical Oncology,2005

2. Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model;Abrey;Journal of Clinical Oncology,2006

3. Upfront thiotepa, busulfan, cyclophosphamide, and autologous stem cell transplantation for primary CNS lymphoma: a single centre experience;Alimohamed;Leukaemia & Lymphoma,2012

4. Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma;Arellano-Rodrigo;European Journal of Haematology,2003

5. Primary CNS lymphoma;Batchelor;Journal of Clinical Oncology,2006

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes of etoposide and cytarabine as consolidation in elderly patients with primary CNS lymphoma;The Oncologist;2024-04-06

2. Bruton’s tyrosine kinase inhibitors in the treatment of primary central nervous system lymphoma: A mini-review;Frontiers in Oncology;2022-11-17

3. Treatment of primary central nervous system lymphomas;Oncohematology;2021-06-07

4. Treatment of Primary Central Nervous System Lymphoma in Immunocompetent Patients;Current Treatment Options in Neurology;2019-07-19

5. Hematopoietic Stem Cell Transplantation for Rare Hematological Malignancies;Hematopoietic Cell Transplantation for Malignant Conditions;2019